Our work in the previous funding period was inspired by synthetic challenges inherent in molecules that directly bind to the ribosome or indirectly impact its function. Structure-activity relationship studies are difficult in these classes of molecules, due to lack of flexible synthetic methods to enable flexible changes to the positioning, stereochemistry and steric environments of key amine and alcohol groups that engage in H- bonding or electrostatic interactions with the binding site; the same is true for altering alkyl and aryl groups that participate in hydrophobic or ?-? interactions. Our versatile methods streamline syntheses of stereochemically complex amine 'triads' present in natural products that inhibit protein synthesis, including aminocyclitols, anthracyclines, and tetracyclines. This enables us to construct 'unnatural products' inspired by bioactive natural products, where diversity can be achieved in: 1) heteroatoms installed in the amine 'triad' building blocks, 2) stereochemical relationships amongst the three contiguous, heteroatom-bearing sp3 carbon centers of the triad, and 3) densely functionalized carbo- and heterocyclic scaffolds. A library of >1000 unique compounds in novel amine chemical space displaying significant stereochemical complexity has shown promising activities against drug-resistant malaria and tuberculosis, Chaga's disease, hepatocellular carcinoma, and other biological targets. This renewal builds on our expertise in securing complex, densely functionalized amine motifs to investigate structure-activity relationships in molecules that impact protein synthesis, primarily through interactions with the ribosome. Analogs of the potent antimalarial natural product jogyamycin will be prepared to probe how binding to the ribosome is impacted; these studies are key to the design of simpler synthetic amine scaffolds that show similar bioactivity, but better selectivity for parasitic vs. eukaryotic mitochondrial ribosomes, lowered toxicity, and less propensity to develop resistance. In the same manner, our expertise in complex amine synthesis will be applied to the design of 'hybrid' anthracyclines that mitigate the toxicity and multi-drug resistance seen in the widely-used antitumor drug doxorubicin (DOX) and other related drugs of significance to the treatment of cancer. We have secured the aid of several collaborators to assess the biological activities of our compounds and provide insight into the design of 2nd-generation libraries, including the Eli Lilly Open Innovation program, GSK (in progress), Corteva Agrisciences, several academic colleagues (Prof. Taifo Mahmud, Prof. Dev Arya, Prof. Silvia Cavagnero, Dr. Desiree Bates), and the University of Wisconsin Medicinal Chemistry Center.

Public Health Relevance

Synthetic compounds able to selectively target prokaryotic over eukaryotic ribosomes to impede protein synthesis are rare. Challenges with pathogens developing resistance towards ribosomal-binding therapeutics, coupled with the synthetic complexity of drugs based on natural products, have reignited interest in 'unnatural products' capable of fulfilling this function. This proposal utilizes versatile synthetic methods to explore new amine chemical space with promising bioactivities that may be related to targeting the ribosome.

Agency
National Institute of Health (NIH)
Institute
National Institute of General Medical Sciences (NIGMS)
Type
Research Project (R01)
Project #
2R01GM111412-06
Application #
9791824
Study Section
Synthetic and Biological Chemistry B Study Section (SBCB)
Program Officer
Yang, Jiong
Project Start
2014-09-01
Project End
2023-08-31
Budget Start
2019-09-15
Budget End
2020-08-31
Support Year
6
Fiscal Year
2019
Total Cost
Indirect Cost
Name
University of Wisconsin Madison
Department
Chemistry
Type
Schools of Arts and Sciences
DUNS #
161202122
City
Madison
State
WI
Country
United States
Zip Code
53715
Schmid, Steven C; Guzei, Ilia A; Fernández, Israel et al. (2018) Ring Expansion of Bicyclic Methyleneaziridines via Concerted, Near-Barrierless [2,3]-Stevens Rearrangements of Aziridinium Ylides. ACS Catal 8:7907-7914
Schmid, Steven C; Guzei, Ilia A; Schomaker, Jennifer M (2017) A Stereoselective [3+1] Ring Expansion for the Synthesis of Highly Substituted Methylene Azetidines. Angew Chem Int Ed Engl 56:12229-12233
Liu, Lu; Gerstner, Nels C; Oxtoby, Lucas J et al. (2017) Fluorinated Amine Stereotriads via Allene Amination. Org Lett 19:3239-3242
Burke, Eileen G; Gold, Brian; Hoang, Trish T et al. (2017) Fine-Tuning Strain and Electronic Activation of Strain-Promoted 1,3-Dipolar Cycloadditions with Endocyclic Sulfamates in SNO-OCTs. J Am Chem Soc 139:8029-8037
Reeves, Ryan D; Phelps, Alicia M; Raimbach, William A T et al. (2017) Diastereoselective Au-Catalyzed Allene Cycloisomerizations to Highly Substituted Cyclopentenes. Org Lett 19:3394-3397
Gerstner, Nels C; Adams, Christopher S; Tretbar, Maik et al. (2016) Stereocontrolled Syntheses of Seven-Membered Carbocycles by Tandem Allene Aziridination/[4+3] Reaction. Angew Chem Int Ed Engl 55:13240-13243
Gerstner, Nels C; Adams, Christopher S; Grigg, R David et al. (2016) Diastereoselective Synthesis of the Aminocyclitol Core of Jogyamycin via an Allene Aziridination Strategy. Org Lett 18:284-7
Burke, Eileen G; Schomaker, Jennifer M (2015) Oxidative allene amination for the synthesis of azetidin-3-ones. Angew Chem Int Ed Engl 54:12097-101
Rigoli, Jared W; Weatherly, Cale D; Alderson, Juliet M et al. (2013) Tunable, chemoselective amination via silver catalysis. J Am Chem Soc 135:17238-41
Rigoli, Jared W; Boralsky, Luke A; Hershberger, John C et al. (2012) 1,4-Diazaspiro[2.2]pentanes as a flexible platform for the synthesis of diamine-bearing stereotriads. J Org Chem 77:2446-55